ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Oncology Trials: Accuracy And Alleviating The Patient Screening Burden

  Flatiron Health has unveiled an innovative service designed to enhance patient screening for clinical trials by integrating structured EHR data with machine learning and human analysis.

• RWD: More Than Just Another Acronym

  Uncover how real-world data can not only be used for any type of clinical trial, but study sponsors can also use RWD to inform all stages of a study.

• Fighting COVID-19 Like A Pro

  Explore how the use of electronic Clinical Outcomes Assessments (eCOAs) can be rapidly implemented to capture patient reported outcomes (PROs).

• Endpoint Adjudication Best Practices: What Top Teams Do Differently

  Poorly designed endpoint adjudication risks trial delays and data errors. Learn to optimize your process by aligning data capture, finalizing charters early, and using true arbitration.

• AI In Clinical Trials: Key Insights From Industry Experts

  Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.

• The Site's Guide To Recovering Clinical Technology Costs From Sponsors

  Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

• Mastering Clinical Trial Forecasting Through Continuous Learning

  Stop treating trial budgets as fixed predictions. Discover how top teams refine financial forecasts by tracking shifting assumptions to improve governance and build trust.

• Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode

  Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.

• RTSM Automating Adaptive Enrollment In Basket Trials

  Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.